• Aucun résultat trouvé

erythropoietin therapy

Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.

Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.

... erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation On day 30 after autologous peripheral blood stem cell transplantation (PBSCT), 20 patients were ...

2

Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.

Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.

... placebo in 50 patients undergoing auto-BMT with purged mar- row for acute myelogenous leukemia or non-Hodgkin’s lym- phoma. The Hb level at day 50 was higher in the rHuEpo group (10.5 versus 9.5 g/dl; P ⫽ 0.02), but this ...

7

Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.

Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.

... transfusion requirements when they are most prominent, i.e. in the first month after transplantation. Tandem autologous HSCT in first-line therapy has been shown to be an optimal treatment option for multiple ...

3

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

... Laboratory analyses Laboratory data were monitored weekly. Complete blood counts were determined in an Advia cell counter (Bayer, Tarrytown, NJ, USA). Serum erythropoietin (EPO) levels were measured just before ...

10

Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.

Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.

... Thus, retrospective studies have shown that it may be possible to predict, soon after initiating therapy with rHuEPO, which patients with cancer- associated anemia are likely to benefit from this particular ...

13

Prediction of response to recombinant human erythropoietin in the anemia of cancer

Prediction of response to recombinant human erythropoietin in the anemia of cancer

... that erythropoietin therapy, using recombinant human erythropoietin (rhEPO) alfa or beta or darbepoietin alfa, can ameliorate the anemia associated with cancer and chemotherapy, reduce the need for ...

42

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.

... REFERENCES 1. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, Korbet S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, ...

8

Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.

Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.

... Erythropoiesis was quantitated both by the ferrokinetic measurement of the erythron transferrin uptake (ETU)3 and the determination of plasma transferrin receptor (TW) levels, which w[r] ...

11

Hormonal therapy and depression: are we overlooking an important therapeutic alternative?: Hormonal therapy and depression

Hormonal therapy and depression: are we overlooking an important therapeutic alternative?: Hormonal therapy and depression

... first-line therapy by 69% of experts for first episodes of mild and moderate depression occurring at perimenopause, antidepressants being recommended as the second ...

37

Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice

Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice

... acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice To coordinate iron supply with hemoglobin (Hb) syn- thesis, erythropoietin (EPO)-stimulated erythroid precur- sors release ...

4

Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.

Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.

... r 1998 by The American Society of Hematology. T HE LEVEL OF BONE MARROW erythropoietic activity depends on the number of erythroid precursors involved in proliferation and differentiation. In the human body, 80% of the ...

7

Can nanotechnology potentiate photodynamic therapy?

Can nanotechnology potentiate photodynamic therapy?

... 2.2. Lipoplexes Lipoplexes are complexes of cationic liposomes with other molecules (most commonly, negatively charged polynucleic acids), and have been most commonly used in gene therapy, for the delivery of ...

37

Prostate segmentation in HIFU therapy.

Prostate segmentation in HIFU therapy.

... II. M ATERIALS The transrectal prostate images used in this study were ac- quired intraoperatively on several Ablatherm devices. The tran- srectal ultrasound probe is composed of two transducers, one for therapy ...

13

Issues in image-guided therapy.

Issues in image-guided therapy.

... 3 SouthEast University, Si Pai Lou 2, Nanjing, 210096,CN * Correspondence should be adressed to: Pascal Haigron <pascal.haigron@univ-rennes1.fr> * Correspondence should be adressed to: Jean-Louis Coatrieux ...

6

From Embryo Research to Therapy

From Embryo Research to Therapy

... intervention on the nuclear genome takes place – it remains integral – and that the mitochondrial genes are not manipulated either. As such, mitochondrial replacement therapy remains different from genome editing ...

13

Photodynamic therapy of cancer: an update.

Photodynamic therapy of cancer: an update.

... cryo- therapy used to treat the contralateral ...after therapy, both treatment groups showed a high response rate (89% for PDT with MAL vs 86% for cryotherapy; P ¼ ...

32

Gene Therapy for ALS—A Perspective

Gene Therapy for ALS—A Perspective

... gene therapy approaches developed for the treatment of ALS are being vigorously ...gene therapy for ALS is especially promising for a specific and stable expression of the therapeutic agent into the ...gene ...

22

The Future of Lipid-Lowering Therapy

The Future of Lipid-Lowering Therapy

... the TG-lowering therapies discussed in this review will ultimately be used in patients that are at risk for ASCVD due to obesity, insulin-resistance and/or suffer from diabetes. These patients are now often treated with ...

17

Personalising metformin therapy: a clinician's perspective

Personalising metformin therapy: a clinician's perspective

... was observed, both for metformin monotherapy (from 8.7±1.3 to 7.0±1.0 % with a mean dose of 1.26±0.47 g/day) and for addition of metformin to sulfonylureas (from 9.2±1.3 to 7.4±1.1 % with a mean dose of 1.29±0.51 ...

5

Radiopharmaceutical dosimetry in targeted radionuclide therapy

Radiopharmaceutical dosimetry in targeted radionuclide therapy

... The different steps of clinical dosimetry in this context includes the determination of the calibration factor of imaging systems, image acquisition and reconstruction, segmentation of[r] ...

251

Show all 972 documents...

Sujets connexes